These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 7435908)
1. Towards safer anaesthesia in sickle cell states. Shaw TJ; Bennett NR Anaesthesia; 1980 Apr; 35(4):394-5. PubMed ID: 7435908 [No Abstract] [Full Text] [Related]
2. Towards safer anesthesia in sickle cell states. Transcutaneous oxygen measurement? Homi J Anaesthesia; 1981 Feb; 36(2):225-6. PubMed ID: 7212241 [No Abstract] [Full Text] [Related]
3. Blood-oxygen affinity and sickling in sickle cell disease: effect of prior deoxygenation. Sinet M; Pocidalo JJ J Lab Clin Med; 1981 Oct; 98(4):492-9. PubMed ID: 6793678 [TBL] [Abstract][Full Text] [Related]
4. Oxygen dissociation curves in sickle cell anemia and in subjects with the sickle cell trait. BECKLAKE MR; GRIFFITHS SB; McGREGOR M; GOLDMAN HI; SCHREVE JP J Clin Invest; 1955 May; 34(5):751-5. PubMed ID: 14367534 [No Abstract] [Full Text] [Related]
5. Cellular mechanism for the protective effect of haemoglobin S against P. falciparum malaria. Pasvol G; Weatherall DJ; Wilson RJ Nature; 1978 Aug; 274(5672):701-3. PubMed ID: 353566 [No Abstract] [Full Text] [Related]
6. Hemoglobin concentration of children with sickle cell trait. Yip R; Nelson PE J Pediatr; 1981 Aug; 99(2):257-8. PubMed ID: 7252688 [No Abstract] [Full Text] [Related]
7. Hypothermic cardiopulmonary bypass in a patient with sickle-cell trait. Fox MA; Abbott TR Anaesthesia; 1984 Nov; 39(11):1121-3. PubMed ID: 6439069 [TBL] [Abstract][Full Text] [Related]
8. Government regulations and sickle cell trait. Cameron BF; Smith DB; Cody B Blood; 1983 Jun; 61(6):1279-80. PubMed ID: 6839027 [No Abstract] [Full Text] [Related]
9. Autologous blood transfusion in patients with sickle cell trait. Romanoff ME; Woodward DG; Bullard WG Anesthesiology; 1988 May; 68(5):820-1. PubMed ID: 3369735 [No Abstract] [Full Text] [Related]
10. Spectrophotometric quantitation of haemoglobin S fraction in heterozygous sickle-cell trait (HbAS). Reid HL; Famodu AA Med Lab Sci; 1988 Apr; 45(2):143-5. PubMed ID: 3210920 [No Abstract] [Full Text] [Related]
11. Falsely low activated clotting time measured in a patient with sickle cell trait. Crook R; Wheeler K Perfusion; 2019 May; 34(4):334-336. PubMed ID: 30628549 [TBL] [Abstract][Full Text] [Related]
12. Use of a tourniquet in patients with sickle-cell disease. Adu-Gyamfi Y; Sankarankutty M; Marwa S Can J Anaesth; 1993 Jan; 40(1):24-7. PubMed ID: 8425239 [TBL] [Abstract][Full Text] [Related]
13. Selected testing of newborns for sickle cell disease. Ohene-Frempong K Pediatrics; 1989 May; 83(5 Pt 2):879-80. PubMed ID: 2717319 [No Abstract] [Full Text] [Related]
19. Serum copper in sickle cell disease. Behera SK; Satpathy KN; Patnaik BK; Panda C; Das D Indian Pediatr; 1981 Jun; 18(6):395-9. PubMed ID: 7287168 [No Abstract] [Full Text] [Related]
20. Genetic model for observed distributions of proportions of haemoglobin in sickle-cell trait. Brittenham G Nature; 1977 Aug; 268(5621):635-6. PubMed ID: 895858 [No Abstract] [Full Text] [Related] [Next] [New Search]